Results 241 to 250 of about 900,764 (306)

Long‐Term Clinical Response After Low‐Dose and Short‐Duration Cemiplimab Therapy in a Patient With Xeroderma Pigmentosum in Nepal

open access: yesJEADV Clinical Practice, EarlyView.
Capsule Summary Xeroderma pigmentosum (XP) is associated with a high risk of multiple and aggressive cutaneous squamous cell carcinomas (CSCCs). The immune checkpoint inhibitor cemiplimab has been approved in advanced, unresectable, and/or metastatic CSCCs.
Sudip Parajuli   +5 more
wiley   +1 more source

Harnessing Generative AI for Lung Nodule Spiculation Characterization. [PDF]

open access: yesJ Imaging Inform Med
Wang Y   +4 more
europepmc   +1 more source

Perilymphatic lung nodules

open access: yes, 2013
Yuranga Weerakkody   +2 more
openaire   +1 more source

WDR72 Drives Esophageal Squamous Cell Carcinoma Progression by Inhibiting Autophagy via the PI3K/Akt/mTOR Pathway

open access: yesThe Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Esophageal squamous cell carcinoma (ESCC) is an aggressive malignancy with a high rate of recurrence and metastasis, necessitating the identification of novel therapeutic targets. WD repeat‐containing protein 72 (WDR72) has been linked to various cancers, but its specific biological function and underlying mechanism in ESCC remain largely ...
Hao Wu, Zhong‐Xiang Jiang, Zheng Jiang
wiley   +1 more source

Lung nodule synthesis guided by customized multi-confidence masks. [PDF]

open access: yesBiomed Eng Lett
Chen H, Liu Y, Liu C, Wang Q, Wang R.
europepmc   +1 more source

Home - About - Disclaimer - Privacy